Have a new insurance plan? Make sure your SKYRIZI is covered.
Resources to stay on track
Useful tools for treatment
Skyrizi Complete has the resources you need before, during and after you start treatment. We can help you:
- Feel confident in the next steps with your prescribed treatment plan, find answers to insurance questions, and get additional savings support from your Skyrizi Complete Nurse Ambassador*
- Understand the infusion process
- Learn how to inject at home after initial training by your healthcare provider
- Use the Skyrizi Complete App to stay on track
*Nurse Ambassadors are provided by AbbVie and do not work under the direction of your health care professional (HCP) or give medical advice. They are trained to direct patients to their HCP for treatment-related advice, including further referrals.
Resources to support you through your prescribed treatment schedule
Treatment with SKYRIZI starts with 3 intravenous (IV) infusions: 1 every 4 weeks, as prescribed by your doctor. You will begin using the On-Body Injector 4 weeks after your third infusion, then every 8 weeks for as long as your doctor prescribes.
Your healthcare provider will let you know where you’ll be receiving your SKYRIZI infusions—this could be an infusion center, your doctor’s office, a hospital, or other location.
Manage your routine with the Skyrizi Complete App
SUPER/ANNOUNCER VOICEOVER (V.O.):
Please see Important Safety Information near the end of this video.
Please see link for the full Prescribing Information, including the Medication Guide, for SKYRIZI.
USES1
SKYRIZI is a prescription medicine used to treat adults with:
- moderate to severe Crohn’s disease.
- moderate to severe ulcerative colitis.
SAFETY CONSIDERATIONS1
Do not use if you are allergic to SKYRIZI. SKYRIZI may cause serious side effects, including serious allergic reactions, an increased risk of infections, and liver problems.
- Stop using SKYRIZI and get emergency medical help right away if experiencing symptoms of a serious allergic reaction.
- Before starting treatment, your doctor should check for infections and tuberculosis. Tell your doctor right away about any infections or symptoms of infection and about planned or recent vaccines.
- Liver problems may happen while being treated for Crohn’s disease or ulcerative colitis that can lead to hospitalization. Your doctor will do liver blood tests before and during treatment and may stop SKYRIZI if liver problems develop.
ANNOUNCER V.O.:
Manage your prescribed treatment anywhere, anytime with the Skyrizi Complete App.
SUPER:
MANAGE TREATMENT ANYWHERE, ANYTIME WITH
The Skyrizi Complete App
[Skyrizi Complete Logo]
ANNOUNCER V.O.:
The App helps you manage your prescribed treatment, whenever.
SUPER:
Helps you manage your prescribed treatment whenever.
ANNOUNCER V.O.:
And lets you access 24/7 live chat and helpful resources all in one place.
SUPER:
Access 24/7 Live Chat and helpful resources all in one place.
SUPER/ANNOUNCER V.O.:
RESOURCES TO HELP BUILD YOUR ROUTINE.
ANNOUNCER V.O.:
You can customize features to help you start—and stick—to your routine.
SUPER:
RESOURCES TO HELP BUILD YOUR ROUTINE
Customize features to help start and stick to a routine.
ANNOUNCER V.O.:
Set reminders, so you never miss a treatment.
Track symptoms, and log injections to share with your doctor.
SUPER:
Set reminders
Track symptoms
Log injections
SUPER/ANNOUNCER V.O.:
RESOURCES WHEN YOU NEED THEM.
ANNOUNCER V.O.:
Right from your phone, you can view infusion and injection prep guides and training refreshers.
You can also watch a video that shows step-by-step instructions for injecting with the SKYRIZI On-Body Injector.
SUPER:
Infusion and injection prep guides
Training refreshers
Step-by-step OBI injection video
ANNOUNCER V.O.:
And if eligible with commercial insurance, access your Skyrizi Complete Savings Card, so you’re always ready to pay for your SKYRIZI treatment.
SUPER:
Access your Savings Card
ANNOUNCER V.O.:
The App gives you all this support and more to manage treatment and build your routine.
Download it today, and take advantage of all the features.
SUPER:
[Skyrizi Complete logo]
Support to manage treatment and build your routine.
Download the Skyrizi Complete App at:
1.866.SKYRIZI
(1.866.759.7494)
—SkyriziComplete.com—
SUPER/V.O.:
IMPORTANT SAFETY INFORMATION1
What is the most important information I should know about SKYRIZI® (risankizumab-rzaa)?
SKYRIZI is a prescription medicine that may cause serious side effects, including:
Serious allergic reactions:
- Stop using SKYRIZI and get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction: - fainting, dizziness, feeling lightheaded (low blood pressure) - swelling of your face, eyelids, lips, mouth, tongue, or throat - trouble breathing or throat tightness - chest tightness - skin rash, hives - itching
Infections:
SKYRIZI may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with SKYRIZI and may treat you for TB before you begin treatment with SKYRIZI if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with SKYRIZI.
- Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including: - fever, sweats, or chills - cough - shortness of breath - blood in your mucus (phlegm) - muscle aches - warm, red, or painful skin or sores on your body different from your psoriasis - weight loss - diarrhea or stomach pain - burning when you urinate or urinating more often than normal
Do not use SKYRIZI if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI. See the Medication Guide or Consumer Brief Summary for a complete list of ingredients.
Before using SKYRIZI, tell your healthcare provider about all of your medical conditions, including if you:
- have any of the conditions or symptoms listed in the section “What is the most important information I should know about SKYRIZI?”
- have an infection that does not go away or that keeps coming back.
- have TB or have been in close contact with someone with TB.
- have recently received or are scheduled to receive an immunization (vaccine). Medicines that interact with the immune system may increase your risk of getting an infection after receiving live vaccines. You should avoid receiving live vaccines right before, during, or right after treatment with SKYRIZI. Tell your healthcare provider that you are taking SKYRIZI before receiving a vaccine.
- are pregnant or plan to become pregnant. It is not known if SKYRIZI can harm your unborn baby.
- are breastfeeding or plan to breastfeed. It is not known if SKYRIZI passes into your breast milk.
- become pregnant while taking SKYRIZI. You are encouraged to enroll in the Pregnancy Registry, which is used to collect information about the health of you and your baby. Talk to your healthcare provider or call 1-877-302-2161 to enroll in this registry.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of SKYRIZI?
SKYRIZI may cause serious side effects. See “What is the most important information I should know about SKYRIZI?”
Liver problems may happen while being treated for Crohn’s disease or ulcerative colitis: A person with Crohn’s disease who received SKYRIZI through a vein in the arm developed changes in liver blood tests with a rash that led to hospitalization. Your healthcare provider will do blood tests to check your liver before, during, and at least up to 12 weeks of treatment, and may stop treatment with SKYRIZI if you develop liver problems. Tell your healthcare provider right away if you notice any of the following symptoms: unexplained rash, nausea, vomiting, stomach (abdominal) pain, tiredness (fatigue), loss of appetite, yellowing of the skin and eyes (jaundice), and dark urine.
The most common side effects of SKYRIZI in people treated for Crohn’s disease and ulcerative colitis include: upper respiratory infections, headache, joint pain, stomach (abdominal) pain, injection site reactions, low red blood cells (anemia), fever, back pain, urinary tract infection, and rash.
These are not all the possible side effects of SKYRIZI. Call your doctor for medical advice about side effects.
Use SKYRIZI exactly as your healthcare provider tells you to use it.
SKYRIZI (risankizumab-rzaa) is available in a 600 mg/10 mL vial for intravenous infusion and a 180 mg/1.2 mL or 360 mg/2.4 mL single-dose prefilled cartridge with on-body injector.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.
SUPER:
Reference: 1. SKYRIZI [package insert]. North Chicago, IL: AbbVie Inc.
Skyrizi Complete Savings Card Terms & Conditions
Eligibility: Available to patients with commercial insurance coverage for SKYRIZI® (risankizumab-rzaa) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit SKYRIZISavingsCard.com or call 1.866.SKYRIZI for additional information. For Full Terms and Conditions for SKYRIZI Crohn’s Disease and Ulcerative Colitis patients, visit www.skyrizi.com/savings-card-terms or call 1.866.SKYRIZI for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy
Please see Important Safety Information near the end of this video.
Please see link for the full Prescribing Information, including the Medication Guide, for SKYRIZI.
[SKYRIZI logo]
[Skyrizi Complete Logo]
[AbbVie logo]
© 2024 AbbVie. All rights reserved. SKYRIZI® and its design are registered trademarks of AbbVie Biotechnology Ltd.
US-SKZG-240569
Get resources with the App
See how the Skyrizi Complete App puts helpful resources right in the palm of your hand.
Getting Ready for Treatment
Understand your treatment
This helpful brochure walks you through your treatment and shows you how SKYRIZI works.
Get the guide for moderate to severe Crohn’s disease ▸
†For eligible, commercially insured patients only. See Terms and Conditions here.
Starting SKYRIZI Infusions
Transitioning to the SKYRIZI On-Body Injector (OBI)
Have questions?
Get support from Skyrizi Complete Specialists when you need a quick answer.
Click the "Chat 24/7” button.
Have a new insurance plan? Make sure your SKYRIZI is covered.
You may also be interested in:
Skyrizi Complete Savings Card Terms & Conditions
Eligibility: Available to patients with commercial insurance coverage for SKYRIZI ® (risankizumab-rzaa) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit www.skyrizi.com/savings-card-terms or call 1.866.SKYRIZI for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.